IFNAR1 and cancer: Following treatment with vehicle or DMXAA (20 mg/kg, i.p. at d3 and d7), we found that DMXAA treatment effectively attenuated cancer-induced mechanical allodynia and cold allodynia in WT mice but not Ifnar1−/− mice (Fig. 3c, d).